Skip to main content
Clinical Trials/NCT06052982
NCT06052982CompletedNot Applicable

Comparative Randomized Study Evaluating Intra and Postoperative Total Blood Loss During Primary Knee Arthroplasty, With Drainage Versus Non-drainage

Groupe Hospitalier Diaconesses Croix Saint-Simon2 sites in 1 country510 target enrollmentStarted: April 10, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
510
Locations
2
Primary Endpoint
Hemoglobin dosage and bleeding quantification in both groups

Study Overview

Brief Summary

Primary arthroplasties are frequent interventions that can present hemorrhagic complications: postoperative hematoma, deglobulization justifying monitoring blood tests and blood transfusion if necessary.

The attitude regarding the drainage of the surgical site supposed to limit these events differs from one surgeon to another, even in the same team. Its use is common practice; for some, systematic. For others, depending on intraoperative findings or the patient's condition. For others, the drain is never laid.

Faced with the divergence of data from the literature on the benefit of the placement of a drain for intra and postoperative bleeding in knee arthroplasty, the lack of randomized prospective studies on large series of patients, and in a desire to homogenization and standardization of the operating procedure of our surgeons, investigators decided to conduct this prospective interventional, comparative and randomized study.

Detailed Description

After obtaining the patient's consent and randomisation, the operating surgeon will have the information of placing or not a drain, lately at the end of the intervention so that the course of the intervention is not influenced by the prior knowledge of the patient randomization arm.

Investigators will carry out especially within the framework of this research 3 samples of a total of 10.7 ml of whole blood (appendix. 12.5) distributed as follows:

Sample no. 1 : 2.7 ml of blood in a hemostasis tube (sodium citrate tube) one day before the procedure (D-1) for the determination of the prothrombin level (PT), activated partial thromboplastin time ( TCA) and the INR or International Normalized Ratio.

Sample no. 2 : 4 ml of blood in a purple EDTA tube for NFS, one day before the operation (D-1) for the determination of hemoglobin ( Hb ) and hematocrit ( Hct ) Sample no. 3 : 4 ml of blood in a violet EDTA tube for NFS for the determination of hemoglobin ( Hb ) and hematocrit ( Hct ) on the fifth postoperative day (D5). This last assessment will be prescribed to the patient to be carried out in the rehabilitation center..

The knee prosthesis implantation surgical technique is performed according to the standard operating procedure of the orthopedic surgery team.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient consent
  • Patient aged over 18 years
  • Patient scheduled for primary knee arthroplasty

Exclusion Criteria

  • Patient expresses his/her opposition to participating in the study
  • Patient scheduled for revision, revision or totalization arthroplasty
  • Primary arthroplasty after septic arthritis
  • Patient requiring an additional planned or unplanned surgical procedure such as TTTA, osteosynthesis for an intraoperative fracture and/or removal of material

Outcomes

Primary Outcomes

Hemoglobin dosage and bleeding quantification in both groups

Time Frame: from the day before surgery until the 5th postoperative day

Estimation of blood loss with Mercuriali Formula. This formula requires the patient's blood volume and requires the volume of red blood cells transfused as well.

Secondary Outcomes

  • Assessment of blood transfusion during primary knee arthroplasty(from surgery until the 5th postoperative day)
  • Number of patients with complications after knee arthroplasty in the two groups(From surgery up to the third month)

Investigators

Sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr LHOTELLIER Luc

Orthopedic surgeon

Groupe Hospitalier Diaconesses Croix Saint-Simon

Study Sites (2)

Loading locations...

Similar Trials